Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations, Bloomberg News reported on Tuesday citing a company executive.
Navigating the complexities of health care can be challenging — especially when it comes to understanding Medicare ...
If these cuts continue, as Medicare has proposed for 2025, we can expect to see additional agency closures and broader ...
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the ...
Open Enrollment period is rapidly approaching. This year Open Enrollment runs from Tuesday, Oct. 15, through Saturday, Dec. 7 ...
The reductions will affect roughly 5,400 members, mostly in Florida, according to a notice to marketing agents.
Read: Social Security will run out of money in 8 years. Is anyone paying attention? It is neither my intent nor my ...
Navigating Medicare can be a complex task for retirees, and accountants play a crucial role in guiding their clients through ...
Original Medicare does not cover root canals, but some Medicare Advantage plans may offer dental coverage. Learn more here.
Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...
It is no surprise that Medicare patients often wait weeks to months for an appointment with a new provider.
President Joe Biden and Vice President Kamala Harris have repeatedly touted on the campaign trail their efforts to lower drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback